When is a protocol deviation considered significant?

A deviation is generally considered significant if it affects the rights, safety, or welfare of subjects, or if it impacts the integrity, reliability, or scientific validity of the study data. The specific criteria for significance are often defined within the study protocol or by regulatory guidelines.

Who is responsible for identifying and reporting protocol deviations?

The investigator and study staff are primarily responsible for identifying and documenting protocol deviations. The investigator is also responsible for reporting significant deviations to the IRB/EC and sponsor, as per regulatory requirements and the study protocol.

All terms

Clinical & TrialsClinical Evidence

Protocol Deviation

Departure from the approved clinical investigation plan.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

Definition

A protocol deviation is any change, divergence, or departure from the study design or procedures defined in the clinical investigation plan that does not have prior IRB/EC approval.

What the regulation says

Regulatory bodies such as the FDA (21 CFR Part 312, Subpart D, and 21 CFR Part 812, Subpart C) and the EU MDR (Article 62 and Annex I, Section 2) mandate that clinical investigations adhere to approved protocols. Protocol deviations, particularly those impacting subject safety, rights, well-being, or data reliability, must be reported to the Institutional Review Board (IRB) or Ethics Committee (EC) and the study sponsor. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6(R2) guideline for Good Clinical Practice (GCP) also emphasizes the importance of protocol adherence and the proper documentation and reporting of deviations.

What this means in practice

Significant deviations affecting subject safety, rights, welfare, or data integrity must be reported to the IRB/EC and sponsor. Trends in deviations indicate a need for site retraining or protocol amendment.

Examples

A clinical research coordinator administers a study drug at a dose slightly different from that specified in the protocol for one patient, without prior approval.
A subject in a clinical trial misses a scheduled follow-up visit, and the visit window specified in the protocol is exceeded.
An investigator enrolls a subject who meets most, but not all, of the pre-defined inclusion criteria outlined in the clinical investigation plan.

Common pitfalls

•Failing to document minor deviations can obscure patterns indicating systemic issues or protocol flaws.
•Not assessing the impact of a deviation on subject safety or data integrity can lead to overlooking serious risks.
•Delaying the reporting of significant deviations can result in non-compliance and compromise study validity.
•Ignoring repeated deviations at a site may indicate inadequate training or a need for protocol clarification rather than isolated incidents.
•Misinterpreting which deviations require immediate reporting can lead to under-reporting or unnecessary administrative burdens.

Frequently asked questions

A protocol deviation is an unplanned departure from the approved protocol, while a protocol amendment is a formal, planned change to the protocol that receives prior IRB/EC approval before implementation.

Cross-references

Part of

A larger framework or document this term belongs to.

ISO 14155

Shared paths + category

Clinical & Trials

Institutional Review Board(IRB)

Board that reviews and approves human-subjects research at an institution.

Clinical Trials & Evidence

Standards

ISO 14155

Good clinical practice for clinical investigations of medical devices.

Clinical Trials & Evidence

Clinical & Trials

ICH E6 Good Clinical Practice(GCP)

International standard for the design, conduct, and reporting of clinical trials.

Same category

Clinical & Trials

Investigator Brochure(IB)

Compilation of clinical and nonclinical information on an investigational device given to clinical investigators, establishes what's 'anticipated' for UADE determinations.

Clinical Trials & Evidence · adjacent

Clinical & Trials

Primary and Secondary Endpoints

The pre-specified outcomes that determine trial success (primary), provide supporting evidence (secondary), or generate hypotheses (exploratory).

Clinical Trials & Evidence · adjacent

Clinical & Trials

Adaptive Trial Design

Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data.

Clinical Trials & Evidence

Latest in MedTech

Primary references

3 sources

Link health: 3 verified· last checked 2026-06-20

ICH·2NIH·1

Inline markers like [1] jump to the matching reference above.

On this term

Category: Clinical & Trials
Sources: 3
Updated: 5/5/2026

Compare with another term

Learn in 60 seconds

Departure from the approved clinical investigation plan.

·Significant deviations affecting subject safety, rights, welfare, or data integrity must be reported to the IRB/EC and sponsor.
·Trends in deviations indicate a need for site retraining or protocol amendment.

Remember this

Watch out: Failing to document minor deviations can obscure patterns indicating systemic issues or protocol flaws.

Related terms

You may also need

Auto-suggested from Clinical & Trials and shared keywords.

All Clinical & Trials terms

From the Blue Goat network

Related resources and services on this topic.

MedTech Launchpad
MedTech funding rounds, accelerators, and launch resources.